These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Type 2 diabetic: risk same as after infarct. With LDL not only the quantity counts]. MMW Fortschr Med; 2004 Jun; 146(24):4. PubMed ID: 15366509 [No Abstract] [Full Text] [Related]
3. Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption. Bruckert E; Giral P; Tellier P Circulation; 2003 Jul; 107(25):3124-8. PubMed ID: 12835406 [No Abstract] [Full Text] [Related]
4. [Hyperlipidemia: decreasing lipid values and effects of statins]. Mathes P Z Kardiol; 2002; 91 Suppl 2():25-9. PubMed ID: 12436762 [No Abstract] [Full Text] [Related]
5. Overlap analysis of the West of Scotland coronary prevention study (WOSCOPS). Lim PO; Yee KM Circulation; 1999 Aug; 100(6):686. PubMed ID: 10441109 [No Abstract] [Full Text] [Related]
6. Updated guidelines support even lower cholesterol levels for at-risk patients. Levenson D Rep Med Guidel Outcomes Res; 2004 Aug; 15(15):1, 6-7. PubMed ID: 15320342 [No Abstract] [Full Text] [Related]
7. [Preventing infarct by lowering LDL. Is 100 the upper limit for every diabetic patient?]. MMW Fortschr Med; 2003 Sep; 145(38):60. PubMed ID: 14603687 [No Abstract] [Full Text] [Related]
9. More than a statin. Underwood A Newsweek; 2004 Aug; 144(6):54. PubMed ID: 15449505 [No Abstract] [Full Text] [Related]
10. LDL-Cholesterol is the King. Goumas GS Angiology; 2009; 60(3):387-8. PubMed ID: 19497926 [No Abstract] [Full Text] [Related]
11. [When statins alone are not enough. Putting a vice grip on cholesterol]. MMW Fortschr Med; 2002 Jun; 144(23):52-3. PubMed ID: 12119909 [No Abstract] [Full Text] [Related]
12. [Following the ASCOT Study. A statin for every hypertensive patient?]. MMW Fortschr Med; 2003 Apr; 145(16):8. PubMed ID: 14606391 [No Abstract] [Full Text] [Related]
13. [Recommended LDL value far lower. How does one achieve this goal?]. Einecke D MMW Fortschr Med; 2004 Mar; 146(13):6. PubMed ID: 15219116 [No Abstract] [Full Text] [Related]
14. [Statins remain the standard. New methods for lipid lowering therapy]. Aumiller J MMW Fortschr Med; 2001 Oct; 143(42):16-7. PubMed ID: 11697281 [No Abstract] [Full Text] [Related]
15. Stricter cholesterol guidelines broaden indications for the 'statin' drugs. Capriotti T Medsurg Nurs; 2003 Feb; 12(1):51-7. PubMed ID: 12619600 [No Abstract] [Full Text] [Related]
16. Impact of nonprescriptive factors on low-density lipoprotein cholesterol reduction with statins. Frolkis JP; Pearce GL; Sprecher DL Am J Cardiol; 2004 Nov; 94(10):1310-2. PubMed ID: 15541255 [TBL] [Abstract][Full Text] [Related]
17. When a statin fails. Med Lett Drugs Ther; 2009 Jul; 51(1317):58-60. PubMed ID: 19636290 [No Abstract] [Full Text] [Related]
18. [Broader indication for treatment with statins; the 'heart protection study']. Cleophas TJ Ned Tijdschr Geneeskd; 2002 Dec; 146(50):2453; author reply 2453-4. PubMed ID: 12518529 [No Abstract] [Full Text] [Related]
19. [Lower, lower, lower. The LDL goal value of 200 mg/dl is still much too high]. Einecke D MMW Fortschr Med; 2004 Mar; 146(13):4-5. PubMed ID: 15219114 [No Abstract] [Full Text] [Related]
20. [Coronary heart disease patient after myocardial infarct. Must LDL cholesterol now be reduced to 70 mg/dl?]]. MMW Fortschr Med; 2005 Dec; 147(49-50):17-8. PubMed ID: 16401004 [No Abstract] [Full Text] [Related] [Next] [New Search]